• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

ARVO Awards Program

Article

The program for Sunday, April 25, features a number of scientific offerings,but one highlight is the annual keynote address. It will be given duringa session scheduled from 5 to 7 p.m. in Ballroom A-D. This year's keynotespeaker is Stephen E. Straus, MD, director, National Center for Complementaryand Alternative Medicine, National Institutes for Health (NIH), Bethesda,MD. His address, entitled "Envisioning New Models for ClinicalResearch", will describe the NIH-developed "Roadmap"-astrategy for accelerating basic science discoveries and for translatingthat research into clinical practice.

Related Videos
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
What keeps you up at night in ophthalmology: Part II
Chris Adams, Diopter Corp CEO
Ramin Valian, of Allergan, discusses pharmaceuticals in the glaucoma industry at Glaucoma 360
© 2024 MJH Life Sciences

All rights reserved.